Abstract
Background: Acquired secondary polycythemia is common in patients with a double outlet right ventricle (DORV) and results from tissue hypoxia. Secondary erythrocytosis can cause coagulation deficiencies and increases the risks of thrombosis and infarction. Perioperative management in DORV patients with severe erythrocytosis is intractable, and only a few cases have been reported. Case presentation: Herein, we report the anesthetic management of a 10-year-old female patient with a DORV. She lived in the low-oxygen Qinghai−Tibet Plateau and presented with severe polycythemia (hemoglobin, 24.8 g/dL; hematocrit, 75%). She underwent a modified Fontan surgery, which was satisfactory and without any perioperative complications. Our anesthetic management highlights the importance of perioperative hemodilution to decrease the risk of thromboembolism and correction of coagulopathy to prevent hemorrhage. Conclusions: Anesthetic management is challenging in rare cyanotic congenital heart disease patients with severe polycythemia. For prevention of thrombosis and hemorrhage, it is important to adopt perioperative hemodilution and correction of coagulopathy.
Introduction: The Challenge of High-Altitude Polycythemia
Severe secondary polycythemia in cyanotic congenital heart disease (CCHD) presents a clinical "double-edged sword." In response to chronic hypoxia—a condition significantly exacerbated by living at high altitudes like the Qinghai-Tibet Plateau—the body overproduces red blood cells to maintain oxygen delivery. In the case of this 10-year-old patient, hemoglobin levels reached 24.8 g/dL with a hematocrit of 75%, nearly double the normal physiological range.
While increased red cell mass supports oxygen transport, it also renders the blood dangerously viscous. This "sludge-like" blood significantly elevates the risk of stroke, organ infarction, and thromboembolism. Paradoxically, this state often depletes clotting factors and platelets, leading to severe coagulopathy. Managing such a patient for complex cardiac surgery requires a delicate balance: thinning the blood to prevent intraoperative clots while simultaneously preparing to manage potentially massive surgical hemorrhage.
Case Presentation: Clinical Management and Surgical Intervention
The patient presented with a complex heart defect known as a Double Outlet Right Ventricle (DORV). Preoperative imaging was essential to map the anatomy before the planned modified Fontan procedure.
The anesthetic strategy prioritized aggressive perioperative hemodilution and precise coagulation management:
- Acute Normovolemic Hemodilution: To lower blood viscosity without compromising iron stores (as traditional phlebotomy might), the team infused 350 mL of crystalloid solution before the first incision.
- Cardiopulmonary Bypass (CPB) Strategy: The heart-lung machine's priming solution was supplemented with crystalloids and albumin to maintain a target hematocrit of 45–55% during the procedure.
- Pharmacological Support: Tranexamic acid was administered early to inhibit fibrinolysis and mitigate the high risk of hemorrhage.
- Advanced Monitoring: Continuous Transesophageal Echocardiography (TEE) was used alongside invasive arterial and central venous pressure (CVP) monitoring to manage cardiac function and volume status in real-time.
The surgical team performed a modified Fontan procedure, involving a total cavapulmonary connection with a 3mm fenestration to allow the patient’s circulation to adapt gradually to the new flow patterns.
Results: Hemodynamic and Hematologic Outcomes
The management strategy resulted in a successful clinical outcome with no thrombotic or major hemorrhagic events. The most significant achievement was the controlled reduction of blood viscosity.
As shown in the table above, hemoglobin was reduced from a preoperative 24.8 g/dL to a stable 15.3 g/dL by postoperative day 8. However, the patient's coagulation markers (PT/INR) worsened significantly by postoperative day 4 before recovering, highlighting the "refractory and tenacious" nature of coagulopathy in severe polycythemia. This required continuous blood product support, including plasma and platelets, during the recovery phase. The patient was successfully extubated on postoperative day 1 and discharged on day 7.
Discussion: Balancing Thrombosis and Hemorrhage
This case underscores that hemodilution is often superior to phlebotomy for high-altitude CCHD patients because it ameliorates hyperviscosity without depleting iron stores or severely compromising oxygen transport capacity.
Success in Fontan surgery specifically depends on maintaining a precise hemodynamic profile: high right atrial pressure to drive blood through the lungs and low pulmonary vascular resistance (PVR). The clinical team achieved this through careful ventilation strategies that avoided high airway pressures and the judicious use of vasoactive support.
A key insight from this case is the slow recovery of the coagulation system. The worsening of PT and INR several days after surgery suggests that the "correction" of clotting factors is a multi-day process in patients with extreme baseline polycythemia.
Conclusion
Anesthetic management of cyanotic congenital heart disease patients with severe polycythemia is a high-stakes balancing act. This case demonstrates that a combination of preoperative hemodilution, meticulous intraoperative monitoring, and aggressive postoperative coagulation support can lead to successful outcomes even in the most extreme cases of high-altitude erythrocytosis. Future management might benefit from the more extensive use of Thromboelastography (TEG) to provide real-time, automated insights into clotting status.
Summary updated